Related content

PERSISTENT ANTIBODY DEPLETION AFTER RITUXIMAB IN THREE CHILDREN WITH AUTOIMMUNE CYTOPENIAS

By Adeli Mehdi Mohammad G.   Eichner Brian H.   Thornburg Courtney   Williams Larry  

Pediatric Hematology and Oncology, Vol. 26, Iss. 8, 2009-11 ,pp. : 566-572

Informa Healthcare

Access to resources Recommend Favorite

Rituximab in children with idiopathic thrombocytopenic purpura: does it really work?

By Russo Giovanna   Licciardello Maria   La Spina Milena  

European Journal of Pediatrics, Vol. 163, Iss. 9, 2004-09 ,pp. : 569-569

Springer Publishing Company

Access to resources Recommend Favorite

HUMAN PARVOVIRUS B19 ASSOCIATED WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA

By Aktepe Orhan   Yetgin Sevgi   Olcay Lale   Özbek Namık  

Pediatric Hematology and Oncology, Vol. 21, Iss. 5, 2004-07 ,pp. : 421-426

Informa Healthcare

Access to resources Recommend Favorite

PARVO VIRUS B19 INCIDENCE AND CHILDHOOD IDIOPATHIC THROMBOCYTOPENIC PURPURA

By Yetgin S.  

Pediatric Hematology and Oncology, Vol. 22, Iss. 4, 2005-06 ,pp. : 347-348

Informa Healthcare

Access to resources Recommend Favorite

Rituximab Therapy to Prevent Relapse in Chronic Relapsing Thrombotic Thrombocytopenic Purpura (TTP) in a Child

By Jayabose Somasundaram   Dunbar Julie   Nowicki Theodore S.   Tugal Oya   Ozkaynak Mehmet Fevzi   Sandoval Claudio  

Pediatric Hematology and Oncology, Vol. 28, Iss. 2, 2011-02 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite